Efficacy and Safety of Thoracic Radiotherapy for Extensive-Stage Small -Cell Lung Cancer in the Era of Immunotherapy: A Real -World Study

被引:0
|
作者
Zhang, C. [1 ]
Wang, W. [1 ]
Deng, L. [2 ]
Bi, N. [1 ]
Zhang, T. [1 ]
Wang, J. [1 ]
Liu, W., Jr. [1 ]
Xiao, Z. [1 ]
Feng, Q. [1 ]
Zhou, Z. [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Radiat Oncol,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Radiat Oncol,Canc Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2193
引用
收藏
页码:E87 / E88
页数:2
相关论文
共 50 条
  • [41] Thoracic Radiotherapy of small cell Lung Cancer in the "extensive disease" Stage
    Becker-Schiebe, M.
    Hoffmann, W.
    ONKOLOGE, 2015, 21 (03): : 259 - 260
  • [42] Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
    Liu, Chaoyuan
    Zeng, Liang
    Deng, Chao
    Jiang, Wenjuan
    Wang, Yapeng
    Zhou, Yiguang
    Liu, Li
    Wang, Sisi
    Zhou, Chunhua
    Qiu, Zhenhua
    Zeng, Fanxu
    Wu, Fang
    Weng, Jie
    Liu, Xianling
    Yang, Nong
    Ma, Fang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy
    Pauls, Mehrnoosh
    Rydz, Natalia
    Nixon, Nancy A.
    Ezeife, Doreen
    BMJ CASE REPORTS, 2021, 14 (01)
  • [44] Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer
    Yee, Don
    Butts, Charles
    Reiman, Anthony
    Joy, Anil
    Smylie, Michael
    Fenton, David
    Chu, Quincy
    Hanson, John
    Roa, Wilson
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 (02) : 234 - 238
  • [45] Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
    Kang, Kai
    Wu, Yijun
    Yao, Zhuoran
    Lu, You
    CANCER LETTERS, 2023, 565
  • [46] Reconsidering the cutoff between sensitive and refractory relapses in extensive-stage small cell lung cancer in the era of immunotherapy
    Torasawa, Masahiro
    Horinouchi, Hidehito
    Nomura, Shogo
    Igawa, Satoshi
    Asai, Maiko
    Ishii, Hidenobu
    Wakui, Hiroshi
    Ushio, Ryota
    Asao, Tetsuhiko
    Namba, Yukiko
    Koyama, Ryo
    Katayama, Isana
    Matsuda, Hironari
    Sasaki, Shinichi
    Takahashi, Kazuhisa
    Hosomi, Yukio
    Naoki, Katsuhiko
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Extensive-stage small cell lung cancer: Is prophylactic cranial irradiation necessary in the era of immunotherapy with MRI surveillance?
    Yao, Yuanhu
    Yao, Nan
    Qin, Zhaohui
    Ma, Ji
    Lu, Jiaying
    Cui, Li
    Qu, Wanxi
    Yuan, Shiwang
    Tong, Shaodong
    Li, Na
    Li, Hao
    PRECISION RADIATION ONCOLOGY, 2023, 7 (02): : 111 - 117
  • [48] Chemo-immunotherapy with or without consolidative radiotherapy in extensive-stage small cell lung cancer: An initial report of clinical outcome and safety
    Bruni, A.
    Bertolini, F.
    D'Angelo, E.
    Barbieri, F.
    Imbrescia, J.
    Trudu, L.
    Cappelli, A.
    Lohr, F.
    Dominici, M.
    Guaitoli, G.
    ANNALS OF ONCOLOGY, 2022, 33 : S100 - S101
  • [49] Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
    Longo, V.
    Vitiello, F.
    Spinnato, F.
    Ambrosio, F.
    Del Giudice, T.
    Sergi, M. C. I.
    Casaluce, F.
    Montrone, M.
    Gilli, M.
    Reale, M. L.
    Di Liello, R.
    Russo, A.
    Sforza, V.
    Gristina, V.
    Servetto, A.
    Cristofano, A.
    Viscardi, G.
    Marchese, A.
    Galetta, D.
    Della Corte, C. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1067 - S1067
  • [50] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Xiaoting Ma
    Shan Wang
    Yujian Zhang
    Huamin Wei
    Jing Yu
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 593 - 606